Form 8-K - Current report:
SEC Accession No. 0001193125-25-069932
Filing Date
2025-04-01
Accepted
2025-04-01 09:19:17
Documents
13
Period of Report
2025-03-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d891291d8k.htm   iXBRL 8-K 33660
  Complete submission text file 0001193125-25-069932.txt   158021

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avir-20250331.xsd EX-101.SCH 2858
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avir-20250331_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avir-20250331_pre.xml EX-101.PRE 11266
15 EXTRACTED XBRL INSTANCE DOCUMENT d891291d8k_htm.xml XML 3639
Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39661 | Film No.: 25796952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)